To summarize, we define how proteasome inhibition alters the chromatin-associated landscape in multiple myeloma by stabilizing repressor complexes at super-enhancers, including the one controlling c-MYC, and at promoters of genes driving proliferation and metabolism (Fig. 6). The gene discussed is MYC; the disease is plasma cell myeloma.